valvulopathy

Related by string. * * FDA defined valvulopathy . cardiac valvulopathy *

Related by context. Frequent words. (Click for all words.) 65 thromboembolic events 64 thromboembolism 63 cerebrovascular events 63 noninferiority 62 hepatotoxicity 61 virologic failure 61 elevated liver enzymes 61 QTc 61 nesiritide 60 motavizumab 60 subgroup analyzes 60 active comparator 60 abatacept 60 fondaparinux 60 tocilizumab 60 teriparatide 59 bosentan 59 thrombotic events 59 glatiramer acetate 59 vertebral fracture 59 cardiotoxicity 59 vandetanib 59 dronedarone 59 carotid artery stenting 59 antiepileptic drug 58 QT prolongation 58 cardiac toxicity 58 myocardial ischemia 58 dutasteride 58 echocardiographic 58 TZDs 58 antithrombotic 58 hs CRP 58 venous thromboembolism 58 virologic response 58 placebo controlled clinical 58 PegIntron 58 hypercalcemia 58 lipid lowering drugs 58 Torisel 58 Pioglitazone 57 microalbuminuria 57 PCa 57 tamsulosin 57 PFO closure 57 PROMACTA 57 achieved statistical significance 57 cardiac dysfunction 57 lacosamide 57 TRITON TIMI 57 adalimumab 57 candesartan 57 intracerebral hemorrhage 57 stable angina 57 atazanavir 57 creatinine clearance 57 Mylotarg 57 elagolix 56 Rivaroxaban 56 ticagrelor 56 left ventricular dysfunction 56 liraglutide 56 carotid stenting 56 dabigatran etexilate 56 angiotensin receptor blockers 56 epithelial ovarian cancer 56 ranolazine 56 reflux disease 56 chemoradiotherapy 56 prospective randomized controlled 56 enalapril 56 hyperkalemia 56 valsartan 56 prespecified 56 temsirolimus 56 tumor recurrence 56 axitinib 56 celecoxib 56 serum cholesterol 56 TORISEL 56 substudy 56 placebo controlled studies 56 mg kg dose 56 myocardial infarctions 56 sunitinib 56 placebo controlled trials 56 LVEF 56 neoadjuvant therapy 56 nonadherence 56 warfarin therapy 56 antihypertensive drugs 56 lamotrigine 56 liver toxicity 56 orthostatic hypotension 55 SRT# [003] 55 antihypertensive medications 55 tanespimycin 55 insulin glargine 55 pramlintide 55 vasomotor symptoms 55 glomerular filtration rate

Back to home page